RGNT · Regentis Biomaterials Ltd.
$1.82
+0.04 (+2.25%)
At close · Jul 29
Market Cap
$9.22M
Shares
5.18M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.78
Open$2.00
Day$1.72–1.99
52W$1.23–8.70
Avg vol 30d814K
Short int81K · 1.6% float · 1.0d
Short vol34%
DataDec 2025–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−35%
below
RSI (14)
37
neutral
MACD trend
Negative
52-week position
7%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−54%
trailing
6-month return
−69%
trailing
YTD return
−74%
this year
Relative strength
−77%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.56% of float · ▼ -43.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
3 holders — 13F breadth
Squeeze score
31
low risk · 0–100
Fundamentals
EPS growth
−1505%
Y/Y
Balance sheet
$7.4M
net cash
Quant / Vol
risk profile
Volatility
273%
annualized · 1-yr
Max drawdown
−83%
past year
ATR
29.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−35%
Bearish
RSI (14)
37
Neutral
MACD trend
Negative
Bearish
52-week position
7%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.56% of float · ▼ -43.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
3 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $1
Now $2 · 7%
52-wk high $9
vs 50-day avg -35%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RGNT
this stock
Regentis Biomaterials Ltd.
|
$9.22M | -73.6% | — | — | 1.6% |
|
ISRG
Intuitive Surgical Inc
|
$127.82B | -36.1% | +20.5% | 41.5 | 1.9% |
|
MDLN
Medline Inc.
|
$53.22B | -3.5% | +11.5% | — | 2.2% |
|
BDX
Becton Dickinson & Co
|
$45.83B | +10.5% | +8.2% | 63.2 | 3.8% |
|
ALC
Alcon Inc
|
$33.70B | -12.3% | +10.5% | — | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
3
- % held
- 10.7%
- Net QoQ
- +270.8K sh
- Top holder
- AIGH Capital Management L…
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RGNT | -11.0% | -54.4% | -69.4% | -49.6% | -73.6% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -10.0% | -54.3% | -76.8% | -48.8% | -82.2% |